Translational Research and Clinical Application of Traditional Chinese Medicine in Cardiovascular Diseases

Overview

Journal JACC Asia

Date 2024 Nov 18

PMID 39553906

Authors

Iokfai Cheang

Ziqi Chen

Xu Zhu

Tongxin Wang

Liping Chang

Rongrong Gao

Zhenhua Jia

Xinli Li

Affiliations

Soon will be listed here.

Abstract

Luobing theory is based on the principles of traditional Chinese medicine (TCM) and focuses on the regulation of blood circulation. The translation of Luobing theory into clinical practice has shown promising results in the treatment of cardiovascular diseases (CVDs). Studies have reported the benefits of using Luobing theory in the treatment of metabolic syndrome, atherosclerosis, arrhythmia, and heart failure. This review article provides an overview of the evidence-based application of TCM Luobing theory in the treatment of CVDs. It also highlights the challenges and opportunities of translating TCM into clinical practice and provides valuable insights for future CVD research.

References

Ji H, Zhao X, Chen X, Fang H, Gao H, Wei G . Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial. JAMA Intern Med. 2024; 184(7):727-735. PMC: 11148787. DOI: 10.1001/jamainternmed.2024.1190. View

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

Savarese G, Becher P, Lund L, Seferovic P, Rosano G, Coats A . Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022; 118(17):3272-3287. DOI: 10.1093/cvr/cvac013. View

Yang H, Wang P, Wang N, Li S, Yang M . Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System. Chin J Integr Med. 2019; 27(7):542-550. DOI: 10.1007/s11655-019-3166-8. View

Eckel R, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. DOI: 10.1016/S0140-6736(05)66378-7. View

Zhao Y, Gao F, Zhang Y, Wang H, Zhu J, Chang L . Shensong Yangxin capsules prevent ischemic arrhythmias by prolonging action potentials and alleviating Ca2+ overload. Mol Med Rep. 2016; 13(6):5185-92. DOI: 10.3892/mmr.2016.5203. View

Li F, Wang J, Song Y, Shen D, Zhao Y, Li C . Qiliqiangxin alleviates Ang II-induced CMECs apoptosis by downregulating autophagy via the ErbB2-AKT-FoxO3a axis. Life Sci. 2021; 273:119239. DOI: 10.1016/j.lfs.2021.119239. View

Wang A, Pu J, Qi X, Miao W, Hou Z, Cong H . [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial]. Zhonghua Yi Xue Za Zhi. 2011; 91(24):1677-81. View

Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023; 83(1):109-279. PMC: 11104284. DOI: 10.1016/j.jacc.2023.08.017. View

10.

Wang D, Tian M, Qi Y, Chen G, Xu L, Zou X . Jinlida granule inhibits palmitic acid induced-intracellular lipid accumulation and enhances autophagy in NIT-1 pancreatic β cells through AMPK activation. J Ethnopharmacol. 2014; 161:99-107. DOI: 10.1016/j.jep.2014.12.005. View

11.

Wang Y, Zhang J, Fu M, Wang J, Cui X, Song Y . Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 Signaling. Curr Pharm Des. 2020; 27(26):2966-2974. DOI: 10.2174/1381612826666201005152709. View

12.

Packer M . Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?. Eur J Heart Fail. 2023; 25(12):2130-2143. DOI: 10.1002/ejhf.3068. View

13.

Wu X, Zhang T, Lyu P, Chen M, Ni G, Cheng H . Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ. Front Cardiovasc Med. 2021; 8:698056. PMC: 8322738. DOI: 10.3389/fcvm.2021.698056. View

14.

Xu Y, Li X, Zhang H, Wu Y, Zhang J, Li J . China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial. Am Heart J. 2020; 227:47-55. PMC: 7305744. DOI: 10.1016/j.ahj.2020.06.011. View

15.

Zhou H, Wang T, Hao Y, Hou Y, Wei C, Yao B . Jinlida Granules Reduce Obesity in db/db Mice by Activating Beige Adipocytes. Biomed Res Int. 2022; 2022:4483009. PMC: 9135524. DOI: 10.1155/2022/4483009. View

16.

Lu Y, Xiang M, Xin L, Zhang Y, Wang Y, Shen Z . Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure. Front Pharmacol. 2022; 13:905424. PMC: 9201726. DOI: 10.3389/fphar.2022.905424. View

17.

Cheang I, Yao W, Zhou Y, Zhu X, Ni G, Lu X . The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial. Nat Med. 2024; 30(8):2295-2302. PMC: 11333273. DOI: 10.1038/s41591-024-03169-2. View

18.

Cheang I, Liao S, Zhu Q, Ni G, Wei C, Jia Z . Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum. Front Pharmacol. 2022; 13:867521. PMC: 8964948. DOI: 10.3389/fphar.2022.867521. View

19.

Oikonomou E, Mourouzis K, Vogiatzi G, Siasos G, Deftereos S, Papaioannou S . Coronary Microcirculation and the No-reflow Phenomenon. Curr Pharm Des. 2018; 24(25):2934-2942. DOI: 10.2174/1381612824666180911122230. View

20.

Pan J, Xu Y, Chen S, Tu Y, Mo Y, Gao F . The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial. J Diabetes Res. 2021; 2021:6303063. PMC: 8519714. DOI: 10.1155/2021/6303063. View